Technology:
Cell_Therapies
Industry:
Finance, Financial Services
Headquarters:
Tokyo, Tokyo, Japan
Funding Status:
Private
Investor Type:
Private Equity Firm
Number Of Exits:
1
Investors Number:
3
Register and Claim Ownership